NCT06249685

Brief Summary

The proposed field trial will clarify the real-world effectiveness of HAs in remediating deficits in emotion processing for older adults with mild-to-moderate hearing loss. This study will employ a repeated reversal design to establish baseline affective state without HAs, when wearing amplification, and after HAs are removed. This study will triangulate self-report, behavioral, and physiological measures to capture nuances of emotional processing in the laboratory and in daily listening. Naturalistic stimuli will be used as it occurs in daily life to elicit emotional experiences, and ecological momentary assessment and commercially-available wearable sensors will be used to track changes in emotional state in daily listening. Anchoring real-world emotional experiences with controlled laboratory experiences will validate wearable sensors. Additionally, laboratory emotional stimuli will be related to real-world emotional experiences to establish the utility of laboratory stimuli in future studies. It is likely that benefits in emotional processing will have differential effects based on individual characteristics (such as degree of hearing loss, age, gender, cognitive ability, and personality), so participants will be analyzed according to larger groupings based on individual differences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 8, 2024

Completed
Last Updated

February 8, 2024

Status Verified

January 1, 2024

Enrollment Period

1.9 years

First QC Date

January 31, 2024

Last Update Submit

January 31, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-reported arousal

    Arousal rating measured with the Self-assessment manikin (SAM)

    Measured several times per day for 6 days in each arm of the study (ecological momentary assessment); and at a lab appointment on day 7; day 28; and day 35 of the trial.

  • Self-reported valence

    Valence rating measured with the Self-assessment manikin (SAM)

    Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.

Secondary Outcomes (10)

  • Self-reported task-load

    Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.

  • Physiological arousal - heart rate

    easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.

  • Physiological arousal - respiration activity

    easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.

  • Physiological arousal - electrodermal responses

    Day 7; day 28; and day 35 of the trial.

  • Physiological valence - electromyography

    Day 7; day 28; and day 35 of the trial.

  • +5 more secondary outcomes

Study Arms (3)

Baseline-Unaided

NO INTERVENTION

No hearing aids.

Aided

EXPERIMENTAL

Fitted with bilateral hearing devices.

Device: Bilateral hearing devices

Follow-up-Unaided

NO INTERVENTION

No hearing aids.

Interventions

Three week trial while wearing bilateral hearing devices.

Also known as: Hearing aid, Hearing aids, Receiver-in-the-canal, RIC
Aided

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Bilateral, uncomplicated, adult-onset mild-to-moderate hearing loss.
  • No previous experience with hearing aids
  • Fluent English speakers
  • Have adequate literacy and cognitive competence to complete informed consent and required questionnaires with minimal assistance.
  • Able to transport themselves to the data collection site and participate in the study without assistance from researchers.

You may not qualify if:

  • History of otologic surgery or chronic middle or outer ear pathology
  • Evidence of retrocochlear involvement
  • Known psychiatric or neurologic disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Memphis

Memphis, Tennessee, 38152, United States

Location

MeSH Terms

Conditions

Hearing LossHearing Loss, Sensorineural

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Study Officials

  • Jani A Johnson, PhD

    University of Memphis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: ABA Repeated Reversal design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 8, 2024

Study Start

July 1, 2020

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

February 8, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations